Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Genetron Holdings Ltd ADR (GTH)

Genetron Holdings Ltd ADR (GTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 127,287
  • Shares Outstanding, K 31,624
  • Annual Sales, $ 94,340 K
  • Annual Income, $ -117,210 K
  • 60-Month Beta 0.50
  • Price/Sales 1.38
  • Price/Cash Flow N/A
  • Price/Book 1.53
Trade GTH with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.54
  • Most Recent Earnings N/A on 10/12/22
  • Latest Earnings Date 05/10/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.84 +4.82%
on 03/20/24
4.05 -0.62%
on 03/28/24
+0.13 (+3.21%)
since 02/28/24
3-Month
3.66 +9.97%
on 12/29/23
4.05 -0.62%
on 03/28/24
+0.33 (+8.78%)
since 12/28/23
52-Week
2.08 +93.49%
on 09/26/23
4.05 -0.62%
on 03/28/24
+1.03 (+34.17%)
since 03/28/23

Most Recent Stories

More News
Stocks Climb Before the Open as Bond Yields Fall, U.S. Inflation Data Looms

December S&P 500 futures (ESZ23) are up +0.43%, and December Nasdaq 100 E-Mini futures (NQZ23) are up +0.46% this morning as U.S. Treasury yields continued to fall, while market participants braced for...

ESZ23 : 4,694.27s (-0.58%)
NQZ23 : 16,530.23s (-0.07%)
GOOGL : 170.68 (+9.41%)
META : 440.62 (-0.17%)
AMGN : 269.90 (+0.19%)
XOM : 116.31 (-4.14%)
DVA : 131.14 (-1.23%)
BAX : 40.13 (-0.25%)
FAST : 68.28 (+0.21%)
DAL : 49.23 (-1.30%)
WBA : 17.87 (+1.53%)
DPZ : 497.31 (+0.51%)
Genetron Health to Participate in the Goldman Sachs Healthcare Corporate Day

BEIJING, June 16, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Receives CAP Accreditation for its Maryland Laboratory

BEIJING, June 15, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Reports Unaudited First Quarter 2022 Financial Results

BEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

BEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Receives CE Mark for FusionScan Plus Kit for Human Multi-Genes

BEIJING, June 01, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022

BEIJING, May 23, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD®

BEIJING, April 19, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Genetron Health Presents 17 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2022

BEIJING, April 08, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)
Publication in Clinical and Translational Medicine Demonstrates Mutation Capsule™’s potential in MRD Assay Developments

BEIJING, April 07, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology...

GTH : 4.03 (+0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Genetron Holdings Limited provides precision oncology platform principally in China. It specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company's product and service portfolio cover the full-cycle of...

See More

Key Turning Points

3rd Resistance Point 4.07
2nd Resistance Point 4.06
1st Resistance Point 4.04
Last Price 4.03
1st Support Level 4.01
2nd Support Level 4.00
3rd Support Level 3.98

See More

52-Week High 4.05
Last Price 4.03
Fibonacci 61.8% 3.30
Fibonacci 50% 3.07
Fibonacci 38.2% 2.83
52-Week Low 2.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar